Association of renal tubular damage with cardio-renal anemia syndrome in patients with heart failure

International Journal of Cardiology

Volumn 173, Issue 2, 2014, Pages 222-228

  Otaki, Yoichiro ^a   Watanabe, Tetsu ^a   Takahashi, Hiroki ^a   Narumi, Taro ^a   Kadowaki, Shinpei ^a   Honda, Yuki ^a   Arimoto, Takanori ^a   Shishido, Tetsuro ^a   Miyamoto, Takuya ^a   Konta, Tsuneo ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Anemia; Cardio renal anemia syndrome; Heart failure; Renal tubular damage

Indexed keywords

BETA 2 MICROGLOBULIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; IRON; BIOLOGICAL MARKER;

AGE; AGED; ANEMIA; ARTICLE; CARDIO RENAL ANEMIA SYNDROME; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART DEATH; HEART DISEASE; HEART FAILURE; HOSPITAL READMISSION; HUMAN; INFLAMMATION; IRON BLOOD LEVEL; IRON DEFICIENCY; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; NORMOCHROMIC NORMOCYTIC ANEMIA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RENAL SYSTEM PARAMETERS; URINARY ALBUMIN TO CREATININE RATIO; URINARY BETA 2 MICROGLOBULIN TO CREATININE RATIO; ANEMIA, IRON-DEFICIENCY; BLOOD; CARDIO-RENAL SYNDROME; EPIDEMIOLOGY; KAPLAN MEIER METHOD; KIDNEY TUBULE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICAL MODEL; URINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIO-RENAL SYNDROME; CONFOUNDING FACTORS (EPIDEMIOLOGY); CREATININE; FEMALE; HEART FAILURE; HUMANS; IRON; KAPLAN-MEIER ESTIMATE; KIDNEY TUBULES; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84898926620     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.02.044     Document Type: Article

References (35)

1. D.M. Lloyd-Jones, M.G. Larson, and E.P. Leip et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study Circulation 106 2002 3068 3072
2. C. Ronco, M. Haapio, A.A. House, N. Anavekar, and R. Bellomo Cardiorenal syndrome J Am Coll Cardiol 52 2008 1527 1539
3. C.Y. Goh, G. Vizzi, M. De Cal, and C. Ronco Cardiorenal syndrome: a complex series of combined heart/kidney disorders Contrib Nephrol 174 2011 33 45
4. P. Martinez-Santos, and I. Vilacosta Cardiorenal syndrome: an unsolved clinical problem Int J Nephrol 2011 2011 913029
5. N. Franchitto, F. Despas, and M. Labrunee et al. Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activity Int J Cardiol 168 2013 2352 2357
6. K.J. Lu, L.G. Kearney, and D.L. Hare et al. Cardiorenal anemia syndrome as a prognosticator for death in heart failure Am J Cardiol 111 2013 1187 1191
7. Y. Otaki, T. Watanabe, and T. Shishido et al. The impact of renal tubular damage, as assessed by urinary beta2-microglobulin-creatinine ratio, on cardiac prognosis in patients with chronic heart failure Circ Heart Fail 6 2013 662 668
8. K. Damman, D.J. Van Veldhuisen, and G. Navis et al. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate Heart 96 2010 1297 1302
9. N. Nakhoul, and V. Batuman Role of proximal tubules in the pathogenesis of kidney disease Contrib Nephrol 169 2011 37 50
10. N. Obara, N. Suzuki, K. Kim, T. Nagasawa, S. Imagawa, and M. Yamamoto Repression via the GATA box is essential for tissue-specific erythropoietin gene expression Blood 111 2008 5223 5232
11. H. Horiguchi, H. Teranishi, and K. Niiya et al. Hypoproduction of erythropoietin contributes to anemia in chronic cadmium intoxication: clinical study on Itai-itai disease in Japan Arch Toxicol 68 1994 632 636
12. A.J. Erslev, and A. Besarab Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure Kidney Int 51 1997 622 630
13. E. O'Meara, T. Clayton, and M.B. McEntegart et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program Circulation 113 2006 986 994
14. D. Mozaffarian, R. Nye, and W.C. Levy Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE) J Am Coll Cardiol 41 2003 1933 1939
15. L. Kleijn, A.M. Belonje, and A.A. Voors et al. Inflammation and anaemia in a broad spectrum of patients with heart failure Heart 98 2012 1237 1241
16. C.S. Weber, L. Beck-da-Silva, L.A. Goldraich, A. Biolo, and N. Clausell Anemia in heart failure: association of hepcidin levels to iron deficiency in stable outpatients Acta Haematol 129 2013 55 61
17. E.A. Jankowska, J. Malyszko, and H. Ardehali et al. Iron status in patients with chronic heart failure Eur Heart J 34 2013 827 834
18. I.C. Macdougall, B. Canaud, and A.L. de Francisco et al. Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency Eur J Heart Fail 14 2012 882 886
19. J. Comin-Colet, C. Enjuanes, and G. Gonzalez et al. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status Eur J Heart Fail 15 2013 1164 1172
20. P.A. McKee, W.P. Castelli, P.M. McNamara, and W.B. Kannel The natural history of congestive heart failure: the Framingham study N Engl J Med 285 1971 1441 1446
21. S. Matsuo, E. Imai, and M. Horio et al. Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 2009 982 992
22. K. Kudo, T. Konta, and Y. Mashima et al. The association between renal tubular damage and rapid renal deterioration in the Japanese population: the Takahata study Clin Exp Nephrol 15 2011 235 241
23. K.U. Eckardt, J.S. Berns, M.V. Rocco, and B.L. Kasiske Definition and classification of CKD: the debate should be about patient prognosis - a position statement from KDOQI and KDIGO Am J Kidney Dis 53 2009 915 920
24. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2002 S1 S266
25. M. Nanami, T. Ookawara, and Y. Otaki et al. Tumor necrosis factor-alpha-induced iron sequestration and oxidative stress in human endothelial cells Arterioscler Thromb Vasc Biol 25 2005 2495 2501
26. G.C. Guidi, and Santonastaso C. Lechi Advancements in anemias related to chronic conditions Clin Chem Lab Med 48 2010 1217 1226
27. H. Horiguchi, E. Oguma, and F. Kayama Cadmium induces anemia through interdependent progress of hemolysis, body iron accumulation, and insufficient erythropoietin production in rats Toxicol Sci 122 2011 198 210
28. J.L. Babitt, and H.Y. Lin Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD Am J Kidney Dis 55 2010 726 741
29. Y. Sasaki, M. Noguchi-Sasaki, H. Yasuno, K. Yorozu, and Y. Shimonaka Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice Int J Hematol 96 2012 692 700
30. M. Nangaku Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure Nephron Exp Nephrol 98 2004 e8 e12
31. M. Nangaku Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure J Am Soc Nephrol 17 2006 17 25
32. M.S. Nieminen, D. Brutsaert, and K. Dickstein et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population Eur Heart J 27 2006 2725 2736
33. K.K. Ho, K.M. Anderson, W.B. Kannel, W. Grossman, and D. Levy Survival after the onset of congestive heart failure in Framingham Heart Study subjects Circulation 88 1993 107 115
34. N. Shiba, and H. Shimokawa Chronic heart failure in Japan: implications of the CHART studies Vasc Health Risk Manag 4 2008 103 113
35. N. Shiba, K. Nochioka, M. Miura, H. Kohno, and H. Shimokawa Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan - first report from the CHART-2 study Circ J 75 2011 823 833